Get the app!
Back to Trades
Total Value
$NaN
Filing Date
Nov 7, 2025
1 transactions

Trade Summary

On Oct 29, 2025, te Boekhorst Paul Francis Olivier, President and CEO, Director, reported $NaN of IMMUCELL CORP /DE/ (ICCC) across 1 transactions. The filing covers company securities and reflects balanced net activity of $NaN. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Company Information

Company Name
IMMUCELL CORP /DE/
Ticker Symbol
ICCC
CIK
0000811641

Insider Information

Role
President and CEO, Director
Location
PORTLAND, ME

Filing Details

Filing Date
Nov 7, 2025
Transaction Date
Oct 29, 2025
Accession Number
0001437749-25-033705
Form Type
3

Want live alerts when te Boekhorst Paul Francis Olivier trades again?

Download Insider Trades to track ICCC, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.